Fmoc-(1S,2S)-2-aminocyclopentane carboxylic acid, 98.0%, 250mg

(R)-2-Amino-3-(4-aminophenyl)propanoic acid, 95.0%, 1g

4-Bromo-2-chloro-5-(trifluoromethyl)benzoic acid, 98%, 500mg

Ipatasertib, 99.88%, 10mg

5-Bromo-2H-spiro[benzofuran-3,4'-piperidine] hydrochloride, 97%, 250mg

4-(2-(PROPYLAMINO)ETHYL)INDOLIN-2-ONE HCL, 95.0%, 250mg

iScope IS.1153-PLi/DFi Triocular with Plan IOS objectives and Rackless cross stage (dark field contrast application)

Fmoc-4-Borono-L-Phenylalanine, 98%, 500mg

2-chloro-1-(chloromethyl)-3,4-dimethoxybenzene, 500mg

(2,4-Dioxo-thiazolidin-3-yl)-acetic acid, 95.0%, 5g

3-Bromophenanthrene-9,10-dione>95.0%(GC)5g

(S)-Methyl 1-Methyl-4,9-Dihydro-3H-Pyrido[3,4-B]Indole-3-Carboxylate Hydroiodide, 98%, 100mg

L(+)-ascorbic acid, min. 99%, pa, 100 g, plastic packaging.